News & Insights A look inside China's growing healthcare and technology sectors

A look inside China's growing healthcare and technology sectors
The Credit Suisse annual China Investment Conference (CIC), now in its ninth year, is one of the most exclusive business gatherings in the Greater China region that brings together institutional investors and corporate leaders. This year’s CIC will take place in Shenzhen, a hub for technological innovation and one of China’s fastest growing cities.

China’s aging population and the healthcare industry

Sources: Credit Suisse, The United Nations "World Population Prospects: The 2017 Revision", CSRI "Emerging Consumer Survey 2017", IMS, Credit Suisse estimates

The CIC presents a wealth of unique insights into the important investment themes driving Chinese markets, from healthcare and biotechnology aimed at tackling the needs of China’s aging population, to artificial intelligence, robotics and China’s emerging young consumer trends that are fueling innovation. The event also offers a platform to forge connections with businesses and corporate leaders from across China and around the world.

Spotlight on healthcare in China

Healthcare will be one of the key topics on the agenda at this year’s event. Experts from the healthcare industry will share their insights into the latest trends in this sector.

China’s aging population represents a significant opportunity for the healthcare industry:

  • By 2035, around one fifth of the population in China is projected to be aged 65 or above, similar to the situation in the UK and the US;
  • The United Nations estimates that by 2060, there will be more than 60 people aged 65 or above for every 100 adults aged between 20-64;
  • Driven by increasing demand and medical reform, China’s healthcare industry is expected to maintain steady growth. By 2030, China’s total annual healthcare costs are estimated to be USD 2.3 trillion, compared to USD 611 billion in 2015, according to the 2017 Credit Suisse Emerging Consumer Survey; 
  • China's pharmaceutical market was worth RMB 1.17 trillion in 2015 and is expected to see a 15% Compound Annual Growth Rate (CAGR) in 2019-21, according to Credit Suisse Research estimates. 

Artificial intelligence, robotics, consumers and more

Technology and innovation are continuing to drive China’s economic transformation. This year’s CIC will also discuss broader technology trends and topics that are highly relevant to investors, such as the ongoing digitalization of industries, artificial intelligence, robotics and how China’s emerging young consumer trends are driving technological developments.

Some 1,000 attendees, including investors, 150 corporates and 50 speakers will gather at the three-day conference to share their informed views on where the next major investment opportunities will come from.

To stay ahead of the investment curve, look out for the latest news on the CIC. It’s an exceptional opportunity to gain access to unconventional investment ideas, learn about the influential trends shaping China’s economy, and receive actionable advice.